Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Angina Pectoris D000787 27 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Scalia S et al. Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles. 2013 Pharm Dev Technol pmid:22998063
Zhang W et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. 2013 Int J Pharm pmid:23876384
Gan L et al. Novel pH-sensitive lipid-polymer composite microspheres of 10-hydroxycamptothecin exhibiting colon-specific biodistribution and reduced systemic absorption. 2013 J Pharm Sci pmid:23605625
Patere SN et al. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. 2013 Curr Drug Deliv pmid:23607649
Bose S et al. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. 2013 Int J Pharm pmid:23262430
Wolska E and Sznitowska M Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM). 2013 Int J Pharm pmid:23164704
Vaghasiya H et al. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. 2013 Eur J Pharm Sci pmid:23557842
Vora C et al. Risk based approach for design and optimization of stomach specific delivery of rifampicin. 2013 Int J Pharm pmid:23916823
Acevedo-Morantes CY et al. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells. 2013 Drug Deliv pmid:24024505
Mohamed RA et al. Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository. 2013 J. Pharm. Pharmacol. pmid:24102470
Stanisz B et al. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. 2013 Drug Dev Ind Pharm pmid:22348774
Bose S and Michniak-Kohn B Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. 2013 Eur J Pharm Sci pmid:23246734
Zhang YT et al. An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers. 2014 J Pharm Sci pmid:25187419
Aburahma MH and Badr-Eldin SM Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. 2014 Expert Opin Drug Deliv pmid:25152197
Zhai H et al. Gastroretentive extended-release floating granules prepared using a novel fluidized hot melt granulation (FHMG) technique. 2014 Mol. Pharm. pmid:25105340
Pivette P et al. Polymorphism of glyceryl behenates: from the individual compounds to the pharmaceutical excipient. 2014 Chem. Phys. Lipids pmid:25062895
Scoutaris N et al. SEM/EDX and confocal Raman microscopy as complementary tools for the characterization of pharmaceutical tablets. 2014 Int J Pharm pmid:24836664
Ravi PR et al. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. 2014 Eur J Pharm Biopharm pmid:24378615
Negi LM et al. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. 2014 Int J Pharm pmid:24345574
Negi JS et al. Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique. 2014 Arch. Pharm. Res. pmid:23695866
Shah MK et al. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. 2014 Pharm Dev Technol pmid:23697916
Vithani K et al. Diclofenac sodium sustained release hot melt extruded lipid matrices. 2014 Pharm Dev Technol pmid:23763447
Pradhan R et al. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate. 2014 Int J Pharm pmid:24184032
Siram K et al. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation. 2014 Expert Opin Drug Deliv pmid:24847779
Uğurlu T and Halaçoğlu MD Effects of some lubricants and evaluation of compression parameters on directly compressible powders. 2014 Pharm Dev Technol pmid:23590449
Tran TH et al. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. 2014 AAPS PharmSciTech pmid:25035071
Makwana V et al. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. 2015 Int J Pharm pmid:26367780
Kakkar S et al. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. 2015 Int J Pharm pmid:26325312
Jeong KH et al. Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate. 2015 Int J Pharm pmid:26315121
Keen JM et al. Continuous twin screw melt granulation of glyceryl behenate: Development of controlled release tramadol hydrochloride tablets for improved safety. 2015 Int J Pharm pmid:25839417
Mužíková J et al. Compressibility of tableting materials and properties of tablets with glyceryl behenate. 2015 Acta Pharm pmid:25781708
Rosiaux Y et al. Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO. 2015 Drug Dev Ind Pharm pmid:25652358
Jannin V et al. Exploring the possible relationship between the drug release of Compritol®-containing tablets and its polymorph forms using micro X-ray diffraction. 2015 J Control Release pmid:25445699
Keen JM et al. Effect of tablet structure on controlled release from supersaturating solid dispersions containing glyceryl behenate. 2015 Mol. Pharm. pmid:25347621
Kim HJ et al. Sustained-release formulation of sarpogrelate hydrochloride. 2015 Arch. Pharm. Res. pmid:24895147
Roberts M et al. Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium. 2015 Pharm Dev Technol pmid:24354893
Jedinger N et al. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids. 2015 Eur J Pharm Biopharm pmid:25733499
Graves RA et al. Effect of squalane on mebendazole-loaded Compritol® nanoparticles. 2015 J Biomater Sci Polym Ed pmid:26062393
Hosny KM et al. Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia. 2015 Drug Des Devel Ther pmid:25609917
Abou Youssef NA et al. Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori. 2015 Int J Pharm pmid:25843757
Shi LL et al. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. 2015 Int J Pharm pmid:25448568
Gönüllü Ü et al. Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. 2015 Acta Pharm pmid:25781700
Refaat A et al. A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets. 2016 Acta Pharm pmid:27749256
Khan S et al. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization. 2016 Eur J Pharm Biopharm pmid:27449630
Sonawane SJ et al. Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies. 2016 Int J Pharm pmid:26992817
Butani D et al. Topical Amphotericin B solid lipid nanoparticles: Design and development. 2016 Colloids Surf B Biointerfaces pmid:26700229
Uğurlu T and Halaçoğlu MD Effects of hexagonal boron nitride on dry compression mixture of Avicel DG and Starch 1500. 2016 Pharm Dev Technol pmid:25716058
Pradhan M et al. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders. 2016 Artif Cells Nanomed Biotechnol pmid:25229831
Punyamurthula NS et al. Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol. 2016 Drug Dev Ind Pharm pmid:26585693
Moazeni M et al. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. 2016 Colloids Surf B Biointerfaces pmid:26974361